IOVA

NASDAQStock

Iovance Biotherapeutics, Inc.

$4.02-0.81 (-16.74%)

52-Week Range

$1.66
$5.41

Key Stats

Market Cap

1.3B

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.74

Volume

22.6M

Avg Volume

23.1M

Performance

1M

+56.54%

3M

+88.43%

6M

+79.30%

YTD

+61.51%

1Y

+15.63%

3Y

-38.80%

5Y

-88.34%

Price Chart

ETF Exposure

IOVA is held by 68 ETFs

ETFFund NameWeight
IWViShares Russell 3000 ETF0.00%
AVTMAvantis Total Equity Markets ETF 10.00%
ITDEiShares LifePath Target Date 2045 ETF0.00%
ITDFiShares LifePath Target Date 2050 ETF0.00%
ITDGiShares LifePath Target Date 2055 ETF0.00%
ITDHiShares LifePath Target Date 2060 ETF0.00%
ITDIiShares LifePath Target Date 2065 ETF0.00%
ITDJiShares LifePath Target Date 2070 ETF0.00%
VTHRVanguard Russell 3000 ETF0.00%
VTIVanguard Total Stock Market ETF0.00%
ITDBiShares LifePath Target Date 2030 ETF0.00%
ITDCiShares LifePath Target Date 2035 ETF0.00%
ITDDiShares LifePath Target Date 2040 ETF0.00%
LSLTPacer Salt Low truBeta US Market ETF0.00%
SLTPacer Salt High truBeta US Market ETF0.00%
TRPLPacer Metaurus US Large Cap Dividend Multiplier 300 ETF0.00%
VETSPacer Military Times Best Employers ETF0.00%
VIRSPacer BioThreat Strategy ETF0.00%
PreviousPage 2 of 2

About IOVA ETF Exposure

Iovance Biotherapeutics, Inc. (IOVA) is held by 68 exchange-traded funds, making it one of the stocks with significant ETF exposure. With a market capitalization of 1.3B, IOVA is a widely held institutional stock. The stock currently trades at $4.02. Investors can gain exposure to IOVA through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold IOVA, sorted by portfolio weight.